Adriana H Tremoulet

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Recurrent fever syndromes in patients after recovery from Kawasaki syndrome
    Lori Broderick
    Department of Pediatrics, University of California San Diego and Rady Children s Hospital, San Diego, California, USA
    Pediatrics 127:e489-93. 2011
  2. pmc Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants
    Adriana H Tremoulet
    Division of Pharmacology and Drug Discovery, Pediatric Pharmacology Research Unit, University of California San Diego, MC 8214, San Diego, CA 92103 8214, USA
    Antimicrob Agents Chemother 51:4297-302. 2007
  3. pmc Developmental pharmacokinetic changes of Lamivudine in infants and children
    Adriana H Tremoulet
    UC San Diego Pediatric Research Center, 7910 Frost St, 360, San Diego, CA 92123, USA
    J Clin Pharmacol 52:1824-32. 2012
  4. pmc Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease
    Alessandra Franco
    Department of Pediatrics, University of California San Diego School of Medicine and Rady Children s Hospital, La Jolla, CA 92093 0641, USA
    Autoimmunity 43:317-24. 2010
  5. pmc Resistance to intravenous immunoglobulin in children with Kawasaki disease
    Adriana H Tremoulet
    Department of Pediatrics, University of California San Diego School of Medicine and Rady Children s Hospital San Diego, San Diego, CA, USA
    J Pediatr 153:117-21. 2008
  6. pmc Recognition of a Kawasaki disease shock syndrome
    John T Kanegaye
    Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, California, USA
    Pediatrics 123:e783-9. 2009

Detail Information

Publications6

  1. pmc Recurrent fever syndromes in patients after recovery from Kawasaki syndrome
    Lori Broderick
    Department of Pediatrics, University of California San Diego and Rady Children s Hospital, San Diego, California, USA
    Pediatrics 127:e489-93. 2011
    ..We propose that these 2 syndromes exist within a family of febrile disorders related to innate immune dysregulation...
  2. pmc Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants
    Adriana H Tremoulet
    Division of Pharmacology and Drug Discovery, Pediatric Pharmacology Research Unit, University of California San Diego, MC 8214, San Diego, CA 92103 8214, USA
    Antimicrob Agents Chemother 51:4297-302. 2007
    ....
  3. pmc Developmental pharmacokinetic changes of Lamivudine in infants and children
    Adriana H Tremoulet
    UC San Diego Pediatric Research Center, 7910 Frost St, 360, San Diego, CA 92123, USA
    J Clin Pharmacol 52:1824-32. 2012
    ..Lamivudine WHO weight band dosing results in therapeutic exposure in infants and children and may improve drug dosing in resource-limited countries...
  4. pmc Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease
    Alessandra Franco
    Department of Pediatrics, University of California San Diego School of Medicine and Rady Children s Hospital, La Jolla, CA 92093 0641, USA
    Autoimmunity 43:317-24. 2010
    ..The large majority of these T-cells displayed the functional phenotype of peripherally induced regulatory T-cells (T(reg)). These findings provide insight into the nature and kinetics of the adaptive immune response in KD...
  5. pmc Resistance to intravenous immunoglobulin in children with Kawasaki disease
    Adriana H Tremoulet
    Department of Pediatrics, University of California San Diego School of Medicine and Rady Children s Hospital San Diego, San Diego, CA, USA
    J Pediatr 153:117-21. 2008
    ..To explore the increased incidence of intravenous immunoglobulin- (IVIG) resistance among San Diego County patients with Kawasaki disease (KD) in 2006 and to evaluate a scoring system to predict IVIG-resistant patients with KD...
  6. pmc Recognition of a Kawasaki disease shock syndrome
    John T Kanegaye
    Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, California, USA
    Pediatrics 123:e783-9. 2009
    ..We sought to define the characteristics that distinguish Kawasaki disease shock syndrome from hemodynamically normal Kawasaki disease...